Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
Clinical trial NCT03992755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03992755
- Sponsor
- Liquidia Technologies, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2025-05-31
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.